Product Information
MICROGESTIN 21 1.5-30 TAB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.3358 per EA under NDC 75907008363. Its NADAC has been published 109 times since Sep 4, 2024.
FDA first approved this application on Mar 20, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
75907008363
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202996FDA Approved
3/20/2014
TE Code
AB
On Market Since
5/1/2024
Price Statistics
The NADAC for MICROGESTIN 21 1.5-30 TAB has been published 109 times since Sep 4, 2024, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3358 per EA |
|---|---|
| All-time high | $0.5130 (Sep 11, 2024) |
| All-time low | $0.3256 (Nov 20, 2024) |
| 52-week high | $0.3923 |
| 52-week low | $0.3344 |
| Median price | $0.3679 |
| Average price | $0.3779 |
| Largest weekly change | -23.1% (Nov 20, 2024) |
| Weeks tracked | 109 |
| Tracking since | Sep 4, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate/Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MICROGESTIN 21 1.5-30 TAB?
The current National Average Drug Acquisition Cost (NADAC) for MICROGESTIN 21 1.5-30 TAB, manufactured by Dr. Reddy's Laboratories Inc., is $0.3358 per EA (NDC 75907008363), effective Sep 30, 2026.
How has the price of MICROGESTIN 21 1.5-30 TAB changed over time?
Over the history we have for it, the NADAC for MICROGESTIN 21 1.5-30 TAB has declined 34.6%. It has been tracked across 109 weekly CMS publications since Sep 4, 2024.
What are the highest and lowest recorded NADAC prices for MICROGESTIN 21 1.5-30 TAB?
Since Sep 4, 2024, the NADAC for MICROGESTIN 21 1.5-30 TAB has ranged from a low of $0.3256 (Nov 20, 2024) to a high of $0.5130 (Sep 11, 2024), with a median of $0.3679 per EA.
Are there cheaper alternatives to MICROGESTIN 21 1.5-30 TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MICROGESTIN 21 1-20 TABLET, is $0.1703 per EA — about 49% below MICROGESTIN 21 1.5-30 TAB.
Who manufactures MICROGESTIN 21 1.5-30 TAB?
MICROGESTIN 21 1.5-30 TAB (NDC 75907008363) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.